Natera $9.5M Genetic Screening Test Billing Settlement

Current Status

Claims are open. The deadline is May 3, 2027, for an online claim or for a paper claim form that the administrator receives by that date; the notice does not give a time of day or a timezone. The court granted preliminary approval on September 2, 2026, and the final approval hearing is set for March 2, 2027 at 9:00 a.m. Pacific. No payment date has been announced, and payments are made only after final approval and the end of any appeals.

What Changed Recently?

Natera, Inc. has agreed to pay $9.5 million to settle Calcaterra v. Natera, Inc., a class action in the U.S. District Court for the Northern District of California. The lawsuit claims that patients were not clearly told about the out-of-pocket costs they could face for Natera’s Panorama noninvasive prenatal test (NIPT) and Horizon genetic carrier screening. Judge Yvonne Gonzalez Rogers granted preliminary approval on September 2, 2026, which opened the claim process. The administrator, Kroll Settlement Administration, began sending email and postcard notices on or after October 2, 2026.

Natera denies wrongdoing. It says patients had access to clear information about the potential costs, that it is in-network with most U.S. health plans, and that the overwhelming majority of patients owe less than $249 or $349, depending on the test and their health plan. Natera says it settled only to avoid the cost and disruption of continued litigation. The court has not decided who is right.

The dispute began in 2021 as a federal case, Copley v. Natera. It was dismissed in 2023 so that it could be refiled in California state court, gained a second plaintiff, and was moved back to federal court by Natera that December, where it became the Calcaterra case. A companion case remains on hold in San Mateo County Superior Court and will be dismissed if this settlement becomes final. The parties reached the agreement after mediation before David Geronemus of JAMS, and signed it on February 26, 2026.

This is a separate case from the earlier $8.25 million Natera prenatal testing settlement, whose claim deadline passed on July 24, 2026.

Who Qualifies?

The class is everyone in the United States who had Panorama noninvasive prenatal testing or Horizon genetic carrier screening performed by Natera between July 10, 2019 and September 2, 2026, and was billed more than the threshold for that test:

• $249 for Panorama without microdeletions
• $349 for Panorama with microdeletions
• $349 for Horizon carrier screening

The class excludes people whose test was paid for entirely by insurance or another third party and who were not billed by Natera, and people tested as part of a clinical trial or research study. Also excluded are Natera and its affiliates, officers, directors and employees, Natera’s counsel of record, the presiding judge and family members, and anyone who opts out.

The court-approved notice says that anyone who received an email or postcard notice was listed as a potential class member.

How Much Can You Get?

Payments come from the net settlement fund: the $9.5 million minus notice and administration costs, attorneys’ fees and expenses, a service award to the named plaintiff, and taxes on the fund. The net fund is split between two groups according to Natera’s own billing records, and the first letter of each class member’s ID shows which group Natera’s records place them in.

• Proof-of-payment group (ID starts with “A”): claimants whose payment above the threshold appears in Natera’s records share 94.7% of the net fund pro rata , in proportion to how much they paid over the threshold for each test.
• No-proof group (ID starts with “B”): claimants whose records show no such payment share 5.3% of the net fund, with each payment capped at $50. If that 5.3% is not used up, the rest moves to the proof-of-payment group.